Citation: 2020 BCSECCOM 72
Cease Trade Order
Usama Chaudhry
George Robinson
(each referred to separately as the Insider)
And
RavenQuest Biomed Inc.
Section 164 of the Securities Act, R.S.B.C. 1996, c. 418
¶ 1 RavenQuest Biomed Inc. is a reporting issuer and has not filed:
1. annual audited financial statements for the year ended October 31, 2019, as required under Part 4 of National Instrument 51-102 Continuous Disclosure Obligations (NI 51-102), and
2. a Form 51-102F1 Management's Discussion and Analysis for the period ended October 31, 2019, as required under Part 5 of NI 51-102
(the required records).
¶ 2 The Insider may have knowledge of, or access to, a material fact or material change regarding RavenQuest Biomed that has not been generally disclosed.
¶ 3 RavenQuest Biomed has agreed to file, immediately after this order is granted, the Notice of Default and, if applicable, Default Status Reports, set out in National Policy 12-203 Management Cease Trade Orders.
¶ 4 Under section 164(1) of the Act, the Executive Director orders that all trading by the Insider in the securities of RavenQuest Biomed cease until:
1. RavenQuest Biomed files the required records, completed in accordance with the Act and rules, and
2. the Executive Director revokes this order.
¶ 5 March 2, 2020
Jody-Ann Edman, CPA, CA
Manager, Financial Reporting
Corporate Finance